Concepedia
Statistics
Publications
9
Citations
208
H-Index
Active since
2013
Affiliations
Tianjin Medical University(Current)
Tianjin First Center Hospital
Nankai University
Apple (Israel)
Chengzhi Lu is an author at Tianjin Medical University specializing in cardiology, medicine, and pharmacology.
Publications per year
2013–2023
A ROS-Responsive Simvastatin Nano-Prodrug and its Fibronectin-Targeted Co-Delivery System for Atherosclerosis Treatment
Runze Zhao, Xiaoyue Ning, Mengqi Wang et al. · ACS Applied Materials & Interfaces · 2022 · 49 citations
Pharmacy, Pharmaceutics, Pharmacology +17
Targeting mitochondria-inflammation circle by renal denervation reduces atheroprone endothelial phenotypes and atherosclerosis
Zhuqing Li, Qi Li, Li Wang et al. · Redox Biology · 2021 · 46 citations · Full text
Life Sciences, Cardiology, Physiology +17
[The effect of catheter based renal synthetic denervation on renin-angiotensin-aldosterone system in patients with resistant hypertension].
Li Wang, Chengzhi Lu, Xin Zhang et al. · PubMed · 2013 · 20 citations
Medicine, Cardiology, Nephrology +15
Galectin-3 inhibition attenuates doxorubicin-induced cardiac dysfunction by upregulating the expression of peroxiredoxin-4
Yunpeng Tian, Wei Lv, Chengzhi Lu et al. · Canadian Journal of Physiology and Pharmacology · 2020 · 20 citations · Full text
Medicine, Cardiology, Pharmacology +17
Maslinic Acid Attenuates Ischemia/Reperfusion Injury-Induced Myocardial Inflammation and Apoptosis by Regulating HMGB1-TLR4 Axis
Qi Li, Mengping Xu, Zhuqing Li et al. · Frontiers in Cardiovascular Medicine · 2021 · 20 citations · Full text
Medicine, Cardiology, Pharmacology +14
1–5 of 9